Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cameron Health Inc.

This article was originally published in Start Up

Executive Summary

Cameron Health believes that the market for implantable cardiac defibrillators (ICDs) is underpenetrated because of the complexity involved in implanting and programming current devices. The company's cardiologist founders created an implantable device that effectively terminates ventricular defibrillation, without using leads that contact the heart directly. Heart leads are the weakest link of current devices, since they can break, become dislodged, or incur infection, Cameron's Health device, which can be implanted subcutaneously in a ten minute procedure should help electrophysiologists handle a higher volume of patients and enable cardiologists to get a share of the procedures as well.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel